Artiva Biotherapeutics, Inc. · NASDAQ:ARTV

Aslan Fred sold 119,771 Artiva Biotherapeutics, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 18, 2026

On Nov 17, 2026, Aslan Fred (Director, Chief Executive Officer) sold 119,771 Artiva Biotherapeutics, Inc. shares at US$3.91 for US$469K, leaving 1,337,657 shares. Filed Nov 18, 2026 (Form 4).

Sold
119,771 shares
Price
US$3.91
Value
US$469K
Holding after
1,337,657 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale119,771US$3.911,337,657Direct

Source

Download original · View original at SEC

Related